share_log

Needham Maintains Buy on Veracyte, Lowers Price Target to $27

Needham Maintains Buy on Veracyte, Lowers Price Target to $27

Needham維持對Veracyte的買入,將目標股價下調至27美元
Benzinga ·  05/08 08:14

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $33 to $27.

尼德姆分析師邁克·馬特森維持Veracyte(納斯達克股票代碼:VCYT)的買入並將目標股價從33美元下調至27美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論